 CURE Pharmaceutical OTC:CURR has signed an agreement with Biopharmaceutical Research Company BRC to produce federally compliant medical cannabis, CBD and THC products. BRC will provide the cannabinoid ingredients and CURE will use them to begin the development of CBD and THC oral thin films for CUREs clinical studies targeted at advancing veteran health. 